TargetMol

Tematropium

Product Code:
 
TAR-T10732
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T10732-1mg1mg£369.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T10732-2mg2mg£470.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T10732-5mg5mg£703.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T10732-1mL1 mL * 10 mM (in DMSO)£785.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T10732-10mg10mg£938.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T10732-25mg25mg£1,380.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T10732-50mg50mg£1,830.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T10732-100mg100mg£2,464.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Tematropium possesses anticholinergic effects and can be used in neurological studies.
CAS:
113932-41-5
Formula:
C21H31NO8S
Molecular Weight:
457.54
Pathway:
Neuroscience
Purity:
0.9887
SMILES:
S(OC)(=O)(=O)[O-].C(C(O[C@H]1C[C@@]2([N+](C)(C)[C@](C1)(CC2)[H])[H])=O)(C(OCC)=O)C3=CC=CC=C3
Target:
AChR

References

1. Buchwald P, et al. Recent advances in the design and development of soft drugs. Pharmazie. 2014 Jun;69(6):403-13. 2. Nigel.L.Web, et al. Fatty acid-anticancer conjugates and uses thereof. CN1377282A